BR112018009288A8 - composições de triglicerídeos de cadeia média - Google Patents
composições de triglicerídeos de cadeia média Download PDFInfo
- Publication number
- BR112018009288A8 BR112018009288A8 BR112018009288A BR112018009288A BR112018009288A8 BR 112018009288 A8 BR112018009288 A8 BR 112018009288A8 BR 112018009288 A BR112018009288 A BR 112018009288A BR 112018009288 A BR112018009288 A BR 112018009288A BR 112018009288 A8 BR112018009288 A8 BR 112018009288A8
- Authority
- BR
- Brazil
- Prior art keywords
- tcm
- medium chain
- chain triglyceride
- triglyceride compositions
- mol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- 229940057917 medium chain triglycerides Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Food Science & Technology (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
a presente invenção refere-se a uma composição que compreende triglicerídeos de cadeia média (tcms), sendo que a composição compreende (i) um tcm que compreende três porções de ácidos graxos, cada uma com 8 átomos de carbono (tcm-c8) e (ii) um tcm que compreende três porções de ácidos graxos, cada uma com 10 átomos de carbono (tcm-c10); em que a razão entre tcm-c8 e tcm-c10 é de 10:90 a 90:10 (mol/mol), e em que a quantidade combinada de tcm-c8 e tcm-c10 constitui ao menos 50 % em mol dos tcms na composição.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15197934 | 2015-12-04 | ||
PCT/EP2016/079521 WO2017093449A1 (en) | 2015-12-04 | 2016-12-02 | Medium chain triglyceride compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112018009288A2 BR112018009288A2 (pt) | 2018-11-06 |
BR112018009288A8 true BR112018009288A8 (pt) | 2019-02-26 |
Family
ID=54849096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018009288A BR112018009288A8 (pt) | 2015-12-04 | 2016-12-02 | composições de triglicerídeos de cadeia média |
Country Status (8)
Country | Link |
---|---|
US (3) | US11000496B2 (pt) |
EP (1) | EP3383383A1 (pt) |
JP (1) | JP7058599B6 (pt) |
CN (2) | CN117017965A (pt) |
AU (1) | AU2016363771B2 (pt) |
BR (1) | BR112018009288A8 (pt) |
CA (1) | CA3004986A1 (pt) |
WO (1) | WO2017093449A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11419350B2 (en) | 2016-07-01 | 2022-08-23 | Corbion Biotech, Inc. | Feed ingredients comprising lysed microbial cells |
BR112020021671A2 (pt) * | 2018-06-07 | 2021-01-26 | Société des Produits Nestlé S.A. | métodos e composições para aumentar os corpos cetônicos em animais |
CN109480284A (zh) * | 2018-12-05 | 2019-03-19 | 上海欣海生物科技有限公司 | 一种生酮食品及其制备方法 |
WO2020127178A1 (en) * | 2018-12-18 | 2020-06-25 | Société des Produits Nestlé S.A. | Dietary propionate |
AU2020246928A1 (en) * | 2019-03-22 | 2021-08-12 | Société des Produits Nestlé S.A. | Methods using administration of medium chain triglycerides (MCT) prior to a meal to increase ketone production from the MCTs |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070179197A1 (en) | 2000-05-01 | 2007-08-02 | Accera, Inc. | Compositions and methods for improving or preserving brain function |
DE60138019D1 (de) | 2000-05-01 | 2009-04-30 | Accera Inc | Verwendung von triglyceriden mit mittellangen ketten zur behandlung und vorbeugung der alzheimerschen erkrankung |
TR201807470T4 (tr) | 2005-12-15 | 2018-06-21 | Nestec Sa | Beyin fonksiyonlarını korumak için bileşimler ve yöntemler. |
ES2544589T3 (es) | 2008-11-06 | 2015-09-01 | The Nisshin Oillio Group, Ltd. | Alimento líquido concentrado |
JP5702292B2 (ja) | 2009-09-30 | 2015-04-15 | 日清オイリオグループ株式会社 | パーキンソン病患者の内臓脂肪減少抑制剤 |
GB201020133D0 (en) | 2010-11-26 | 2011-01-12 | Royal Holloway & Bedford New College | Therapeutic use of compounds |
WO2013066151A1 (en) | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Improving recognition |
TWI572352B (zh) * | 2012-03-01 | 2017-03-01 | 波麥堤克藥學Smt有限公司 | 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法 |
GB201210699D0 (en) | 2012-06-15 | 2012-08-01 | Vitaflo Ltd | Nutritional food |
AU2014235034A1 (en) | 2013-03-15 | 2015-10-01 | Buck Institute For Research On Aging | Improved cognitive supplements |
WO2015052847A1 (ja) | 2013-10-11 | 2015-04-16 | ジャパンエレベーターサービス株式会社 | メンテナンスコンソール |
-
2016
- 2016-12-02 CN CN202310990778.0A patent/CN117017965A/zh active Pending
- 2016-12-02 EP EP16809686.5A patent/EP3383383A1/en active Pending
- 2016-12-02 US US15/780,492 patent/US11000496B2/en active Active
- 2016-12-02 CA CA3004986A patent/CA3004986A1/en active Pending
- 2016-12-02 JP JP2018525699A patent/JP7058599B6/ja active Active
- 2016-12-02 WO PCT/EP2016/079521 patent/WO2017093449A1/en active Application Filing
- 2016-12-02 CN CN201680067187.4A patent/CN108348496A/zh active Pending
- 2016-12-02 BR BR112018009288A patent/BR112018009288A8/pt not_active Application Discontinuation
- 2016-12-02 AU AU2016363771A patent/AU2016363771B2/en active Active
-
2021
- 2021-01-26 US US17/158,328 patent/US11857527B2/en active Active
-
2023
- 2023-11-22 US US18/518,044 patent/US20240082199A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2017093449A1 (en) | 2017-06-08 |
US20240082199A1 (en) | 2024-03-14 |
CN117017965A (zh) | 2023-11-10 |
BR112018009288A2 (pt) | 2018-11-06 |
JP7058599B6 (ja) | 2022-08-01 |
US11857527B2 (en) | 2024-01-02 |
CN108348496A (zh) | 2018-07-31 |
EP3383383A1 (en) | 2018-10-10 |
JP2018537091A (ja) | 2018-12-20 |
JP7058599B2 (ja) | 2022-04-22 |
AU2016363771A1 (en) | 2018-04-26 |
US11000496B2 (en) | 2021-05-11 |
US20180353455A1 (en) | 2018-12-13 |
US20210145782A1 (en) | 2021-05-20 |
CA3004986A1 (en) | 2017-06-08 |
AU2016363771B2 (en) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018009288A2 (pt) | composições de triglicerídeos de cadeia média | |
BR112014031284B8 (pt) | composição, produto de cuidado pessoal, e, modificador de reologia | |
CL2019001631A1 (es) | Formulación de mezcla que comprende células y un ácido graso poliinsaturado que tiene al menos 20 átomos de carbono (lc-pufa). | |
TW201613488A (en) | Nutritional compositions containing oil blends and uses thereof | |
BR112018003578A2 (pt) | composições de óleo refinado e métodos para fazer | |
BR112017008595A2 (pt) | composições e métodos referentes à beta-glucosidase | |
NZ716341A (en) | Glyceride composition | |
BR112017010453A2 (pt) | composição adesiva com mudança de cor | |
BR112017011810A2 (pt) | geração de canola transgênica com baixo ou sem ácidos graxos saturados | |
BR112015024332A2 (pt) | sonda fluorescente para estanho | |
BR112015021813A2 (pt) | éster de isononila na base de misturas de ácidos graxos de óleos vegetais | |
BR112015001728B8 (pt) | composições de condicionador | |
BR112012013010A2 (pt) | poliésteres de sacarose | |
BR112017019059A2 (pt) | composição de aditivo para composição de borracha composta de sílica, composição de borracha e pneu | |
BR112016025931A8 (pt) | composição de barra de sabão extrudada, barra e método para intensificar a transparência das barras de sabão | |
BR112015001616B8 (pt) | Método para aumento do teor de sus em um óleo ou em uma fração de oleína por intraesterificação 1,3-específica, óleo ou oleína intraesterificado 1,3-seletivo e seu uso | |
MX2018004128A (es) | Composiciones de aceite y metodos para elaborarlas. | |
BR112014017048A2 (pt) | emulsão orgânica compreendendo dha e epa | |
BR112017004325A2 (pt) | composição nutricional para uso na promoção da maturação e/ou do reparo do intestino e/ou do fígado | |
MX2020006759A (es) | Composicion util como modificador de friccion. | |
MY177028A (en) | Solid compositions of triglycerides and uses thereof | |
EA201690768A1 (ru) | Состав, предотвращающий некротический энтерит у домашних птиц | |
BR112016029165A2 (pt) | método para degomagem de composições contendo triglicerídeos | |
BR112017014681A2 (pt) | composição de ácido graxo | |
BR112017002944A2 (pt) | turbina a vapor e método para operação de uma turbina a vapor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |